Literature DB >> 27157029

Acceptance and Commitment Therapy for Problematic Internet Pornography Use: A Randomized Trial.

Jesse M Crosby1, Michael P Twohig2.   

Abstract

Problematic Internet pornography use is the inability to control the use of pornography, the experience of negative cognitions or emotions regarding pornography use, and the resulting negative effects on quality of life or general functioning. This study compared a 12-session individual protocol of acceptance and commitment therapy (ACT) for problematic Internet pornography use to a waitlist control condition with 28 adult males, all but 1 of whom were members of the Church of Jesus Christ of Latter-day Saints. Measures of self-reported pornography viewing, standardized measures of compulsive sexual behavior and related cognitions, and quality of life occurred at pretreatment, posttreatment, and 3-month follow-up. Results demonstrate significant between-condition reductions in pornography viewing compared to the waitlist condition (93% reduction ACT vs. 21% waitlist). When combining all participants (N=26), a 92% reduction was seen at posttreatment and an 86% reduction at 3-month follow-up. Complete cessation was seen in 54% of participants at posttreatment and at least a 70% reduction was seen in 93% of participants. At the 3-month follow-up assessment, 35% of participants showed complete cessation, with 74% of participants showing at least 70% reduction in viewing. Treatment suggestions and future directions are discussed.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  acceptance and commitment therapy; pornography use; treatment

Mesh:

Year:  2016        PMID: 27157029     DOI: 10.1016/j.beth.2016.02.001

Source DB:  PubMed          Journal:  Behav Ther        ISSN: 0005-7894


  8 in total

1.  Psychometric Properties of the Problematic Pornography Use Scale in a Japanese Sample.

Authors:  Yushun Okabe; Daisuke Ito
Journal:  Arch Sex Behav       Date:  2021-12-01

2.  Effectiveness of Acceptance and Commitment Therapy on Anxiety and Depression of Razi Psychiatric Center Staff.

Authors:  Mostafa Heydari; Saideh Masafi; Mehdi Jafari; Seyed Hassan Saadat; Shima Shahyad
Journal:  Open Access Maced J Med Sci       Date:  2018-02-08

Review 3.  Toward Actionable Practice Parameters for "Dual Diagnosis": Principles of Assessment and Management for Co-Occurring Psychiatric and Intellectual/Developmental Disability.

Authors:  John N Constantino; Shae Strom; Michael Bunis; Cy Nadler; Teresa Rodgers; Julia LePage; Connie Cahalan; Amber Stockreef; Lucas Evans; Rachel Jones; Alyssa Wilson
Journal:  Curr Psychiatry Rep       Date:  2020-02-01       Impact factor: 5.285

4.  Hands-off: Feasibility and preliminary results of a two-armed randomized controlled trial of a web-based self-help tool to reduce problematic pornography use.

Authors:  Beáta Bőthe; Christian Baumgartner; Michael P Schaub; Zsolt Demetrovics; Gábor Orosz
Journal:  J Behav Addict       Date:  2021-10-29       Impact factor: 6.756

Review 5.  An integrated model to assess and treat compulsive sexual behaviour disorder.

Authors:  Peer Briken
Journal:  Nat Rev Urol       Date:  2020-06-19       Impact factor: 14.432

6.  Exploring the Etiological Pathways of Problematic Pornography Use in NoFap/PornFree Rebooting Communities: A Critical Narrative Analysis of Internet Forum Data.

Authors:  Dimitra Chasioti; James Binnie
Journal:  Arch Sex Behav       Date:  2021-06-18

7.  Mindfulness and Behavior Change.

Authors:  Zev Schuman-Olivier; Marcelo Trombka; David A Lovas; Judson A Brewer; David R Vago; Richa Gawande; Julie P Dunne; Sara W Lazar; Eric B Loucks; Carl Fulwiler
Journal:  Harv Rev Psychiatry       Date:  2020 Nov/Dec       Impact factor: 3.732

8.  Hands-off: Study protocol of a two-armed randomized controlled trial of a web-based self-help tool to reduce problematic pornography use.

Authors:  Beáta Bőthe; Christian Baumgartner; Michael P Schaub; Zsolt Demetrovics; Gábor Orosz
Journal:  J Behav Addict       Date:  2020-06       Impact factor: 6.756

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.